-
BD Highlights the Latest Innovations in Drug Delivery at Pharmapack 2025
PharmaSources
January 21, 2025
In January 2025, BD, a global medical tech firm, will display drug - delivery innovations at Pharmapack in Paris, engage in educational sessions, present diverse products, and invest in tech and manufacturing for patient - centered systems.
-
Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform
B3C newswire
November 06, 2023
The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform.
-
serYmun Yeast Announces Preclinical Safety and Efficacy Data for Their Yeast-Based Vaccine Against Porcine Parvovirus (PPV)
PharmaSources
March 06, 2023
an animal health vaccine development company based in Germany, announces the breakthrough in the development of their first pig vaccine candidate against porcine parvovirus.
-
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries
PharmaSources.com
April 12, 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
-
Could COVID-19 vaccines be swallowed?
EuropeanPharmaceuticalReview
February 10, 2022
New pre-clinical research demonstrates the potential of gastric autoinjectors to deliver mRNA in sufficient quantities for vaccination.
-
Coriolis Pharma Opens New ATMP Formulation Development Facilities
B3Cnewswire
February 07, 2022
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines...
-
DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield
ExpressPharma
January 28, 2022
The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals for meeting the emerging needs of drugs or vaccines
-
Air of optimism surrounds lung cancer vaccine
pharmatimes
January 18, 2022
Cancer Research UK announces clinical trial for most common type of lung cancer
-
While Omicron continues to dominate across the world, COVID-19 travel requirements remain
pharmatimes
January 15, 2022
The scandal surrounding Novak Djokovic’s entry into Australia, following his vaccine exemption, has sparked outcry on both a national and global scale.
-
New study adds more evidence for Omicron immune evasion
WorldPharmaNews
December 27, 2021
A new study from Columbia researchers, in collaboration with scientists at the University of Hong Kong, S.A.R., China, adds more evidence that the omicron variant can evade the immune protection conferred by vaccines...